This article focuses on Dr Avi Schroeder of Israel’s Technion Institute. His company PEEP Therapeutics is developing a cancer treatment based on Elephant protein gene P53.  He is also working on personalized chemotherapy and a cure for a deadly shrimp … Continue reading →

Israel’s Oncohost is working with Israel’s Technion to develop cutting-edge technology to characterize, analyze and predict patient response and resistance to cancer therapy. This enables personalized treatment strategies with improved outcomes & reduced side effects. http://oncohost.com/ https://www.jpost.com/Jpost-Tech/Hillels-Tech-Corner-Cancer-treatment-personalized-610032

Researchers at Israel’s Technion Institute have used artificial intelligence and big data to decode the unique signatures of certain cancer cells. The resulting technology – dubbed a “computerized pathologist” –could significantly boost development of personalized cancer treatments. https://www.israel21c.org/deep-learning-tech-reveals-personal-id-of-cancer-cells/

I reported previously (see here) on Israeli startup Telesofia when it developed personalized medical videos. Now Israel’s Sheba Medical Center is to pilot Telesofia’s tele-medicine software for cancer patients at home to communicate with doctors about chemotherapy side effects. https://www.timesofisrael.com/oncologist-startup-develop-software-that-monitors-cancer-patients-at-home/

I reported previously (see here) on Israeli biotech Ayala and its personalized cancer treatment. It is already partnering with Bristol-Myers Squibb. Now multinational Novartis has made a $|10 million investment in Ayala, focusing on the aggressive blood cancer multiple myeloma. … Continue reading →

Scientists at Israel’s Technion Institute have developed nano-packages of different anti-cancer treatments that are tagged with synthetic DNA sequences. Released into the bloodstream and collected 48 hours later, they identify which treatments are most effective. http://www.technion.ac.il/en/2016/11/personalized-cancer-therapy/

Israeli biotech Rosetta Genomics boosted its molecular diagnostics capability by purchasing PersonalizeDx in the United States. Rosetta also received US patent protection for its cancer tests. http://www.businesswire.com/news/home/20150414005159/en/Rosetta-Genomics-Completes-Acquisition-PersonalizeDx#.VVzo8VIpqSp   http://www.businesswire.com/news/home/20150513005723/en/Rosetta-Genomics-Receives-Additional-U.S.-Patent-Protection#.VVzpr1IpqSp

(thanks to NoCamels) IBM Haifa has been developing its Clinical Genomics platform since 2007. It has announced that it can now deliver personal treatment recommendations based on an automated interpretation of pathology guidelines, as well as cases documented in hospital … Continue reading →

Personally tailored treatments for cancer patients are well known. Now Tel Aviv University researchers propose a similar approach to fighting infections. Two immune markers in the blood indicate which medication and dosage can best fight the pathogen and repair the … Continue reading →